Cargando…

Current understanding of CTLA-4: from mechanism to autoimmune diseases

Autoimmune diseases (ADs) are characterized by the production of autoreactive lymphocytes, immune responses to self-antigens, and inflammation in related tissues and organs. Cytotoxic T-lymphocyte antigen 4 (CTLA-4) is majorly expressed in activated T cells and works as a critical regulator in the i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hossen, Md Munnaf, Ma, Yanmei, Yin, Zhihua, Xia, Yuhao, Du, Jing, Huang, Jim Yi, Huang, Jennifer Jin, Zou, Linghua, Ye, Zhizhong, Huang, Zhong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10367421/ https://www.ncbi.nlm.nih.gov/pubmed/37497212 http://dx.doi.org/10.3389/fimmu.2023.1198365

Ejemplares similares

Metallothionein-1 is Positively Correlated with Inflammation and Ankylosing Spondylitis Activity
por: Ma, Yanmei, et al.
Publicado: (2022)

Opportunistic Autoimmune Disorders Potentiated by Immune-Checkpoint Inhibitors Anti-CTLA-4 and Anti-PD-1
por: Kong, Yi-chi M., et al.
Publicado: (2014)

Autoimmunity-Related Risk Variants in PTPN22 and CTLA4 Are Associated With ME/CFS With Infectious Onset
por: Steiner, Sophie, et al.
Publicado: (2020)

Current Understanding and Recent Developments in Common Variable Immunodeficiency Associated Autoimmunity
por: Gereige, Jessica D., et al.
Publicado: (2019)

IL-37 restrains autoimmune diseases
por: Ye, Liang, et al.
Publicado: (2015)

Corrigendum: Urine L-selectin reflects clinical and histological renal disease activity and treatment response in lupus nephritis across multi-ethnicity
por: Shen, Yiwei, et al.
Publicado: (2023)

Urine L-selectin reflects clinical and histological renal disease activity and treatment response in lupus nephritis across multi-ethnicity
por: Shen, Yiwei, et al.
Publicado: (2023)

Genome-Wide Identification and Functional Analysis of Lysine Histidine Transporter (LHT) Gene Families in Maize
por: Rabby, Md. Golam, et al.
Publicado: (2022)

TGFβ2 Induces the Soluble Isoform of CTLA-4 – Implications for CTLA-4 Based Checkpoint Inhibitor Antibodies in Malignant Melanoma
por: Khanolkar, Rahul C., et al.
Publicado: (2022)

Polymorphisms and Circulating Plasma Protein Levels of Immune Checkpoints (CTLA-4 and PD-1) Are Associated With Posner-Schlossman Syndrome in Southern Chinese
por: Huang, Xiaosheng, et al.
Publicado: (2021)

Editorial: Understanding the concept of pre-clinical autoimmunity
por: Olsen, Nancy J., et al.
Publicado: (2022)

Risk of Ankylosing Spondylitis in Patients With Endometriosis: A Population-Based Retrospective Cohort Study
por: Yin, Zhihua, et al.
Publicado: (2022)

CTLA-4 Synergizes With PD1/PD-L1 in the Inhibitory Tumor Microenvironment of Intrahepatic Cholangiocarcinoma
por: Guo, Xiao-Jun, et al.
Publicado: (2021)

Clinical Implications of Aberrant PD-1 and CTLA4 Expression for Cancer Immunity and Prognosis: A Pan-Cancer Study
por: Liu, Jian-Nan, et al.
Publicado: (2020)

Current Understanding of Circular RNAs in Systemic Lupus Erythematosus
por: Liu, Hongjiang, et al.
Publicado: (2021)

Successful Treatment of T Cell-Mediated Acute Rejection with Delayed CTLA4-Ig in Mice
por: Young, James S., et al.
Publicado: (2017)

Inborn Errors of Immunity and Their Phenocopies: CTLA4 and PD-1
por: Hao, Yuwei, et al.
Publicado: (2022)

Impact of CTLA-4 checkpoint antibodies on ligand binding and Transendocytosis
por: Williams, Cayman, et al.
Publicado: (2022)

CTLA-4 and Autoimmunity: New Twists in the Tale
por: Walker, Lucy S.K.
Publicado: (2015)

Understanding the Multifaceted Role of Neutrophils in Cancer and Autoimmune Diseases
por: Wang, Xu, et al.
Publicado: (2018)

Understanding CD4(+) T cells in autoimmune bullous diseases
por: Lee, A Yeong, et al.
Publicado: (2023)

CTLA4 mRNA is downregulated by miR-155 in regulatory T cells, and reduced blood CTLA4 levels are associated with poor prognosis in metastatic melanoma patients
por: Vaddi, Prasanna Kumar, et al.
Publicado: (2023)

Mitochondria in innate immunity signaling and its therapeutic implications in autoimmune diseases
por: Jiao, Yuhao, et al.
Publicado: (2023)

Diverse Mechanisms Regulate the Surface Expression of Immunotherapeutic Target CTLA-4
por: Schneider, Helga, et al.
Publicado: (2014)

Increased Risk for Malignancies in 131 Affected CTLA4 Mutation Carriers
por: Egg, David, et al.
Publicado: (2018)

Sirtuins in osteoarthritis: current understanding
por: Liu, Yikai, et al.
Publicado: (2023)

CTLA-4: a negative regulator of autoimmune disease
Publicado: (1996)

A case of autoimmune enteropathy with CTLA4 haploinsufficiency
por: Miyazaki, Haruka, et al.
Publicado: (2022)

Chimeric CTLA4-CD28-CD3z T Cells Potentiate Antitumor Activity Against CD80/CD86–Positive B Cell Malignancies
por: Lin, Shouheng, et al.
Publicado: (2021)

Beyond CTLA-4 and PD-1, the Generation Z of Negative Checkpoint Regulators
por: Le Mercier, Isabelle, et al.
Publicado: (2015)

Do common infections trigger disease-onset or -severity in CTLA-4 insufficiency?
por: Krausz, Máté, et al.
Publicado: (2022)

Genetic variants of CTLA4 are associated with clinical outcome of patients with multiple myeloma
por: Gonzalez-Montes, Yolanda, et al.
Publicado: (2023)

Bispecific antibodies targeting CTLA-4: game-changer troopers in cancer immunotherapy
por: Farhangnia, Pooya, et al.
Publicado: (2023)

Epigenetic Changes Associated With Interleukin-10
por: Zheng, Zhonghua, et al.
Publicado: (2020)

Emerging Role of Dipeptidyl Peptidase-4 in Autoimmune Disease
por: Huang, Jie, et al.
Publicado: (2022)

Crosstalk Between Gut Microbiota and Innate Immunity and Its Implication in Autoimmune Diseases
por: Jiao, Yuhao, et al.
Publicado: (2020)

Autoimmune Addison's Disease as Part of the Autoimmune Polyglandular Syndrome Type 1: Historical Overview and Current Evidence
por: Perniola, Roberto, et al.
Publicado: (2021)

CTLA-4 and PD-1 Control of T-Cell Motility and Migration: Implications for Tumor Immunotherapy
por: Brunner-Weinzierl, Monika C., et al.
Publicado: (2018)

Preponderance of CTLA4 Variation Associated With Autosomal Dominant Immune Dysregulation in the MYPPPY Motif
por: Siggs, Owen M., et al.
Publicado: (2019)

Gene and protein expression of a soluble form of CTLA-4 in a healthy dog
por: TAGAWA, Michihito, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_hc7si11jh56c1k9qg2p22edgtg